AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
15.6|16.2|15.9|11401|All ICCC Groups Combined|71920580|0-19|All Races|Male and Female|1999|15.6|16.1|15.9
4.0|4.3|4.1|2978|I Leukemias, myeloproliferative & myelodysplastic diseases|71920580|0-19|All Races|Male and Female|1999|4.0|4.3|4.1
3.0|3.2|3.1|2218|I(a) Lymphoid leukemias|71920580|0-19|All Races|Male and Female|1999|3.0|3.2|3.1
0.8|0.9|0.8|586|I(b) Acute myeloid leukemias|71920580|0-19|All Races|Male and Female|1999|0.8|0.9|0.8
0.1|0.1|0.1|70|I(c) Chronic myeloproliferative diseases|71920580|0-19|All Races|Male and Female|1999|0.1|0.1|0.1
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|71920580|0-19|All Races|Male and Female|1999|~|~|~
0.1|0.2|0.1|94|I(e) Unspecified and other specified leukemias|71920580|0-19|All Races|Male and Female|1999|0.1|0.2|0.1
2.2|2.4|2.3|1673|II Lymphomas and reticuloendothelial neoplasms|71920580|0-19|All Races|Male and Female|1999|2.2|2.4|2.3
1.1|1.3|1.2|849|II(a) Hodgkin lymphomas|71920580|0-19|All Races|Male and Female|1999|1.1|1.3|1.2
0.7|0.8|0.8|551|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|71920580|0-19|All Races|Male and Female|1999|0.7|0.8|0.8
0.2|0.3|0.2|175|II(c) Burkitt lymphoma|71920580|0-19|All Races|Male and Female|1999|0.2|0.3|0.2
0.1|0.1|0.1|55|II(d) Miscellaneous lymphoreticular neoplasms|71920580|0-19|All Races|Male and Female|1999|0.1|0.1|0.1
0.0|0.1|0.1|43|II(e) Unspecified lymphomas|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.1
2.7|3.0|2.8|2040|III CNS and misc intracranial and intraspinal neoplasms|71920580|0-19|All Races|Male and Female|1999|2.7|3.0|2.8
0.2|0.3|0.3|183|III(a) Ependymomas and choroid plexus tumor|71920580|0-19|All Races|Male and Female|1999|0.2|0.3|0.3
1.2|1.4|1.3|954|III(b) Astrocytomas|71920580|0-19|All Races|Male and Female|1999|1.2|1.4|1.3
0.6|0.7|0.7|493|III(c) Intracranial and intraspinal embryonal tumors|71920580|0-19|All Races|Male and Female|1999|0.6|0.7|0.7
0.4|0.5|0.5|333|III(d) Other gliomas|71920580|0-19|All Races|Male and Female|1999|0.4|0.5|0.5
0.0|0.1|0.1|36|III(e) Other specified intracranial & intraspinal neoplasms|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.1
0.0|0.1|0.1|41|III(f) Unspecified intracranial and intraspinal neoplasms|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.1
0.8|0.9|0.8|585|IV Neuroblastoma and other peripheral nervous cell tumors|71920580|0-19|All Races|Male and Female|1999|0.7|0.9|0.8
0.7|0.9|0.8|566|IV(a) Neuroblastoma and ganglioneuroblastoma|71920580|0-19|All Races|Male and Female|1999|0.7|0.9|0.8
0.0|0.0|0.0|19|IV(b) Other peripheral nervous cell tumors|71920580|0-19|All Races|Male and Female|1999|0.0|0.0|0.0
1.0|1.1|1.1|767|IX Soft tissue and other extraosseous sarcomas|71920580|0-19|All Races|Male and Female|1999|1.0|1.1|1.1
0.4|0.5|0.5|324|IX(a) Rhabdomyosarcomas|71920580|0-19|All Races|Male and Female|1999|0.4|0.5|0.5
0.1|0.1|0.1|80|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|71920580|0-19|All Races|Male and Female|1999|0.1|0.1|0.1
~|~|~|~|IX(c) Kaposi sarcoma|71920580|0-19|All Races|Male and Female|1999|~|~|~
0.3|0.4|0.4|270|IX(d) Other specified soft tissue sarcomas|71920580|0-19|All Races|Male and Female|1999|0.3|0.4|0.4
0.1|0.2|0.1|90|IX(e) Unspecified soft tissue sarcomas|71920580|0-19|All Races|Male and Female|1999|0.1|0.2|0.1
0.0|0.0|0.0|23|Not classified by ICCC|71920580|0-19|All Races|Male and Female|1999|0.0|0.0|0.0
0.3|0.4|0.3|230|V Retinoblastoma|71920580|0-19|All Races|Male and Female|1999|0.3|0.4|0.3
0.6|0.7|0.6|460|VI Renal tumors|71920580|0-19|All Races|Male and Female|1999|0.6|0.7|0.6
0.5|0.6|0.6|419|VI(a) Nephroblastoma and other nonepithelial renal tumors|71920580|0-19|All Races|Male and Female|1999|0.5|0.6|0.6
0.0|0.1|0.1|37|VI(b) Renal carcinomas|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.1
~|~|~|~|VI(c) Unspecified malignant renal tumors|71920580|0-19|All Races|Male and Female|1999|~|~|~
0.2|0.2|0.2|144|VII Hepatic tumors|71920580|0-19|All Races|Male and Female|1999|0.2|0.2|0.2
0.1|0.2|0.1|92|VII(a) Hepatoblastoma|71920580|0-19|All Races|Male and Female|1999|0.1|0.2|0.1
0.1|0.1|0.1|51|VII(b) Hepatic carcinomas|71920580|0-19|All Races|Male and Female|1999|0.1|0.1|0.1
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|71920580|0-19|All Races|Male and Female|1999|~|~|~
0.8|1.0|0.9|631|VIII Malignant bone tumors|71920580|0-19|All Races|Male and Female|1999|0.8|0.9|0.9
0.5|0.6|0.5|367|VIII(a) Osteosarcomas|71920580|0-19|All Races|Male and Female|1999|0.5|0.6|0.5
0.0|0.1|0.0|25|VIII(b) Chondrosarcomas|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.0
0.2|0.3|0.3|197|VIII(c) Ewing tumor and related sarcomas of bone|71920580|0-19|All Races|Male and Female|1999|0.2|0.3|0.3
0.0|0.1|0.0|32|VIII(d) Other specified malignant bone tumors|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.0
~|~|~|~|VIII(e) Unspecified malignant bone tumors|71920580|0-19|All Races|Male and Female|1999|~|~|~
0.9|1.1|1.0|729|X Germ cell, trophoblastic tumors & neoplasms of gonads|71920580|0-19|All Races|Male and Female|1999|0.9|1.1|1.0
0.1|0.2|0.1|101|X(a) Intracranial & intraspinal germ cell tumors|71920580|0-19|All Races|Male and Female|1999|0.1|0.2|0.1
0.1|0.2|0.1|99|X(b) Malignant extracranial & extragonadal germ cell tumors|71920580|0-19|All Races|Male and Female|1999|0.1|0.2|0.1
0.6|0.7|0.7|485|X(c) Malignant gonadal germ cell tumors|71920580|0-19|All Races|Male and Female|1999|0.6|0.7|0.7
0.0|0.1|0.0|31|X(d) Gonadal carcinomas|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.0
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|71920580|0-19|All Races|Male and Female|1999|~|~|~
1.4|1.6|1.5|1089|XI Other malignant epithelial neoplasms and malignant melanomas|71920580|0-19|All Races|Male and Female|1999|1.4|1.6|1.5
~|~|~|~|XI(a) Adrenocortical carcinomas|71920580|0-19|All Races|Male and Female|1999|~|~|~
0.5|0.6|0.6|422|XI(b) Thyroid carcinomas|71920580|0-19|All Races|Male and Female|1999|0.5|0.6|0.6
0.0|0.1|0.1|39|XI(c) Nasopharyngeal carcinomas|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.1
0.4|0.5|0.5|334|XI(d) Malignant melanomas|71920580|0-19|All Races|Male and Female|1999|0.4|0.5|0.5
~|~|~|~|XI(e) Skin carcinomas|71920580|0-19|All Races|Male and Female|1999|~|~|~
0.3|0.4|0.4|272|XI(f) Other and unspecified carcinomas|71920580|0-19|All Races|Male and Female|1999|0.3|0.4|0.4
0.1|0.1|0.1|52|XII Other and unspecified malignant neoplasms|71920580|0-19|All Races|Male and Female|1999|0.1|0.1|0.1
~|~|~|~|XII(a) Other specified malignant tumors|71920580|0-19|All Races|Male and Female|1999|~|~|~
0.0|0.1|0.1|38|XII(b) Other unspecified malignant tumors|71920580|0-19|All Races|Male and Female|1999|0.0|0.1|0.1
15.9|16.5|16.2|11905|All ICCC Groups Combined|73649093|0-19|All Races|Male and Female|2000|15.9|16.5|16.2
4.0|4.3|4.1|3030|I Leukemias, myeloproliferative & myelodysplastic diseases|73649093|0-19|All Races|Male and Female|2000|4.0|4.3|4.1
3.1|3.3|3.2|2342|I(a) Lymphoid leukemias|73649093|0-19|All Races|Male and Female|2000|3.1|3.3|3.2
0.6|0.8|0.7|520|I(b) Acute myeloid leukemias|73649093|0-19|All Races|Male and Female|2000|0.6|0.8|0.7
0.1|0.1|0.1|65|I(c) Chronic myeloproliferative diseases|73649093|0-19|All Races|Male and Female|2000|0.1|0.1|0.1
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|73649093|0-19|All Races|Male and Female|2000|~|~|~
0.1|0.2|0.1|94|I(e) Unspecified and other specified leukemias|73649093|0-19|All Races|Male and Female|2000|0.1|0.2|0.1
2.4|2.6|2.5|1819|II Lymphomas and reticuloendothelial neoplasms|73649093|0-19|All Races|Male and Female|2000|2.4|2.6|2.5
1.1|1.3|1.2|896|II(a) Hodgkin lymphomas|73649093|0-19|All Races|Male and Female|2000|1.1|1.3|1.2
0.7|0.9|0.8|598|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|73649093|0-19|All Races|Male and Female|2000|0.7|0.9|0.8
0.2|0.3|0.3|200|II(c) Burkitt lymphoma|73649093|0-19|All Races|Male and Female|2000|0.2|0.3|0.3
0.1|0.1|0.1|75|II(d) Miscellaneous lymphoreticular neoplasms|73649093|0-19|All Races|Male and Female|2000|0.1|0.1|0.1
0.1|0.1|0.1|50|II(e) Unspecified lymphomas|73649093|0-19|All Races|Male and Female|2000|0.1|0.1|0.1
2.9|3.1|3.0|2191|III CNS and misc intracranial and intraspinal neoplasms|73649093|0-19|All Races|Male and Female|2000|2.9|3.1|3.0
0.2|0.3|0.2|170|III(a) Ependymomas and choroid plexus tumor|73649093|0-19|All Races|Male and Female|2000|0.2|0.3|0.2
1.5|1.6|1.5|1140|III(b) Astrocytomas|73649093|0-19|All Races|Male and Female|2000|1.5|1.6|1.5
0.6|0.7|0.7|480|III(c) Intracranial and intraspinal embryonal tumors|73649093|0-19|All Races|Male and Female|2000|0.6|0.7|0.7
0.4|0.5|0.4|321|III(d) Other gliomas|73649093|0-19|All Races|Male and Female|2000|0.4|0.5|0.4
0.0|0.1|0.0|32|III(e) Other specified intracranial & intraspinal neoplasms|73649093|0-19|All Races|Male and Female|2000|0.0|0.1|0.0
0.0|0.1|0.1|48|III(f) Unspecified intracranial and intraspinal neoplasms|73649093|0-19|All Races|Male and Female|2000|0.0|0.1|0.1
0.7|0.8|0.7|548|IV Neuroblastoma and other peripheral nervous cell tumors|73649093|0-19|All Races|Male and Female|2000|0.7|0.8|0.7
0.7|0.8|0.7|540|IV(a) Neuroblastoma and ganglioneuroblastoma|73649093|0-19|All Races|Male and Female|2000|0.7|0.8|0.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|73649093|0-19|All Races|Male and Female|2000|~|~|~
1.1|1.3|1.2|870|IX Soft tissue and other extraosseous sarcomas|73649093|0-19|All Races|Male and Female|2000|1.1|1.3|1.2
0.4|0.5|0.5|355|IX(a) Rhabdomyosarcomas|73649093|0-19|All Races|Male and Female|2000|0.4|0.5|0.5
0.1|0.1|0.1|87|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|73649093|0-19|All Races|Male and Female|2000|0.1|0.1|0.1
~|~|~|~|IX(c) Kaposi sarcoma|73649093|0-19|All Races|Male and Female|2000|~|~|~
0.4|0.5|0.4|325|IX(d) Other specified soft tissue sarcomas|73649093|0-19|All Races|Male and Female|2000|0.4|0.5|0.4
0.1|0.2|0.1|99|IX(e) Unspecified soft tissue sarcomas|73649093|0-19|All Races|Male and Female|2000|0.1|0.2|0.1
0.0|0.0|0.0|18|Not classified by ICCC|73649093|0-19|All Races|Male and Female|2000|0.0|0.0|0.0
0.3|0.4|0.3|233|V Retinoblastoma|73649093|0-19|All Races|Male and Female|2000|0.3|0.4|0.3
0.6|0.7|0.7|486|VI Renal tumors|73649093|0-19|All Races|Male and Female|2000|0.6|0.7|0.7
0.6|0.7|0.6|450|VI(a) Nephroblastoma and other nonepithelial renal tumors|73649093|0-19|All Races|Male and Female|2000|0.6|0.7|0.6
0.0|0.1|0.0|35|VI(b) Renal carcinomas|73649093|0-19|All Races|Male and Female|2000|0.0|0.1|0.0
~|~|~|~|VI(c) Unspecified malignant renal tumors|73649093|0-19|All Races|Male and Female|2000|~|~|~
0.2|0.2|0.2|134|VII Hepatic tumors|73649093|0-19|All Races|Male and Female|2000|0.2|0.2|0.2
0.1|0.2|0.1|107|VII(a) Hepatoblastoma|73649093|0-19|All Races|Male and Female|2000|0.1|0.2|0.1
0.0|0.1|0.0|27|VII(b) Hepatic carcinomas|73649093|0-19|All Races|Male and Female|2000|0.0|0.1|0.0
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|73649093|0-19|All Races|Male and Female|2000|~|~|~
0.8|0.9|0.8|622|VIII Malignant bone tumors|73649093|0-19|All Races|Male and Female|2000|0.8|0.9|0.8
0.4|0.5|0.5|352|VIII(a) Osteosarcomas|73649093|0-19|All Races|Male and Female|2000|0.4|0.5|0.5
~|~|~|~|VIII(b) Chondrosarcomas|73649093|0-19|All Races|Male and Female|2000|~|~|~
0.3|0.3|0.3|223|VIII(c) Ewing tumor and related sarcomas of bone|73649093|0-19|All Races|Male and Female|2000|0.3|0.3|0.3
0.0|0.0|0.0|18|VIII(d) Other specified malignant bone tumors|73649093|0-19|All Races|Male and Female|2000|0.0|0.0|0.0
0.0|0.0|0.0|16|VIII(e) Unspecified malignant bone tumors|73649093|0-19|All Races|Male and Female|2000|0.0|0.0|0.0
1.0|1.1|1.1|781|X Germ cell, trophoblastic tumors & neoplasms of gonads|73649093|0-19|All Races|Male and Female|2000|1.0|1.1|1.1
0.1|0.2|0.2|122|X(a) Intracranial & intraspinal germ cell tumors|73649093|0-19|All Races|Male and Female|2000|0.1|0.2|0.2
0.1|0.2|0.1|101|X(b) Malignant extracranial & extragonadal germ cell tumors|73649093|0-19|All Races|Male and Female|2000|0.1|0.2|0.1
0.6|0.8|0.7|509|X(c) Malignant gonadal germ cell tumors|73649093|0-19|All Races|Male and Female|2000|0.6|0.8|0.7
0.0|0.1|0.0|33|X(d) Gonadal carcinomas|73649093|0-19|All Races|Male and Female|2000|0.0|0.1|0.0
0.0|0.0|0.0|16|X(e) Other and unspecified malignant gonadal tumors|73649093|0-19|All Races|Male and Female|2000|0.0|0.0|0.0
1.4|1.6|1.5|1128|XI Other malignant epithelial neoplasms and malignant melanomas|73649093|0-19|All Races|Male and Female|2000|1.4|1.6|1.5
0.0|0.0|0.0|22|XI(a) Adrenocortical carcinomas|73649093|0-19|All Races|Male and Female|2000|0.0|0.0|0.0
0.5|0.6|0.5|404|XI(b) Thyroid carcinomas|73649093|0-19|All Races|Male and Female|2000|0.5|0.6|0.5
0.0|0.1|0.1|40|XI(c) Nasopharyngeal carcinomas|73649093|0-19|All Races|Male and Female|2000|0.0|0.1|0.1
0.4|0.6|0.5|367|XI(d) Malignant melanomas|73649093|0-19|All Races|Male and Female|2000|0.4|0.6|0.5
~|~|~|~|XI(e) Skin carcinomas|73649093|0-19|All Races|Male and Female|2000|~|~|~
0.3|0.4|0.4|289|XI(f) Other and unspecified carcinomas|73649093|0-19|All Races|Male and Female|2000|0.3|0.4|0.4
0.0|0.1|0.1|45|XII Other and unspecified malignant neoplasms|73649093|0-19|All Races|Male and Female|2000|0.0|0.1|0.1
~|~|~|~|XII(a) Other specified malignant tumors|73649093|0-19|All Races|Male and Female|2000|~|~|~
0.0|0.1|0.0|31|XII(b) Other unspecified malignant tumors|73649093|0-19|All Races|Male and Female|2000|0.0|0.1|0.0
16.6|17.2|16.9|12658|All ICCC Groups Combined|74878093|0-19|All Races|Male and Female|2001|16.6|17.2|16.9
4.4|4.7|4.6|3404|I Leukemias, myeloproliferative & myelodysplastic diseases|74878093|0-19|All Races|Male and Female|2001|4.4|4.7|4.5
3.2|3.5|3.3|2471|I(a) Lymphoid leukemias|74878093|0-19|All Races|Male and Female|2001|3.2|3.4|3.3
0.7|0.8|0.8|573|I(b) Acute myeloid leukemias|74878093|0-19|All Races|Male and Female|2001|0.7|0.8|0.8
0.2|0.2|0.2|156|I(c) Chronic myeloproliferative diseases|74878093|0-19|All Races|Male and Female|2001|0.2|0.2|0.2
0.1|0.2|0.2|114|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74878093|0-19|All Races|Male and Female|2001|0.1|0.2|0.2
0.1|0.1|0.1|90|I(e) Unspecified and other specified leukemias|74878093|0-19|All Races|Male and Female|2001|0.1|0.1|0.1
2.3|2.6|2.4|1832|II Lymphomas and reticuloendothelial neoplasms|74878093|0-19|All Races|Male and Female|2001|2.3|2.6|2.4
1.2|1.3|1.2|930|II(a) Hodgkin lymphomas|74878093|0-19|All Races|Male and Female|2001|1.2|1.3|1.2
0.8|0.9|0.9|653|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74878093|0-19|All Races|Male and Female|2001|0.8|0.9|0.9
0.2|0.2|0.2|160|II(c) Burkitt lymphoma|74878093|0-19|All Races|Male and Female|2001|0.2|0.2|0.2
0.1|0.1|0.1|56|II(d) Miscellaneous lymphoreticular neoplasms|74878093|0-19|All Races|Male and Female|2001|0.1|0.1|0.1
0.0|0.1|0.0|33|II(e) Unspecified lymphomas|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.0
2.8|3.1|2.9|2196|III CNS and misc intracranial and intraspinal neoplasms|74878093|0-19|All Races|Male and Female|2001|2.8|3.1|2.9
0.2|0.3|0.2|179|III(a) Ependymomas and choroid plexus tumor|74878093|0-19|All Races|Male and Female|2001|0.2|0.3|0.2
1.4|1.6|1.5|1093|III(b) Astrocytomas|74878093|0-19|All Races|Male and Female|2001|1.4|1.5|1.5
0.6|0.7|0.6|485|III(c) Intracranial and intraspinal embryonal tumors|74878093|0-19|All Races|Male and Female|2001|0.6|0.7|0.6
0.4|0.5|0.5|369|III(d) Other gliomas|74878093|0-19|All Races|Male and Female|2001|0.4|0.5|0.5
0.0|0.1|0.1|43|III(e) Other specified intracranial & intraspinal neoplasms|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.1
0.0|0.1|0.0|27|III(f) Unspecified intracranial and intraspinal neoplasms|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.0
0.8|1.0|0.9|672|IV Neuroblastoma and other peripheral nervous cell tumors|74878093|0-19|All Races|Male and Female|2001|0.8|1.0|0.9
0.8|0.9|0.9|659|IV(a) Neuroblastoma and ganglioneuroblastoma|74878093|0-19|All Races|Male and Female|2001|0.8|0.9|0.9
~|~|~|~|IV(b) Other peripheral nervous cell tumors|74878093|0-19|All Races|Male and Female|2001|~|~|~
1.1|1.2|1.2|874|IX Soft tissue and other extraosseous sarcomas|74878093|0-19|All Races|Male and Female|2001|1.1|1.2|1.2
0.4|0.5|0.5|361|IX(a) Rhabdomyosarcomas|74878093|0-19|All Races|Male and Female|2001|0.4|0.5|0.5
0.1|0.2|0.1|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74878093|0-19|All Races|Male and Female|2001|0.1|0.2|0.1
~|~|~|~|IX(c) Kaposi sarcoma|74878093|0-19|All Races|Male and Female|2001|~|~|~
0.4|0.5|0.4|306|IX(d) Other specified soft tissue sarcomas|74878093|0-19|All Races|Male and Female|2001|0.4|0.5|0.4
0.1|0.1|0.1|92|IX(e) Unspecified soft tissue sarcomas|74878093|0-19|All Races|Male and Female|2001|0.1|0.2|0.1
0.0|0.1|0.0|26|Not classified by ICCC|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.0
0.3|0.4|0.3|246|V Retinoblastoma|74878093|0-19|All Races|Male and Female|2001|0.3|0.4|0.3
0.6|0.7|0.7|500|VI Renal tumors|74878093|0-19|All Races|Male and Female|2001|0.6|0.7|0.7
0.6|0.7|0.6|456|VI(a) Nephroblastoma and other nonepithelial renal tumors|74878093|0-19|All Races|Male and Female|2001|0.6|0.7|0.6
0.0|0.1|0.1|42|VI(b) Renal carcinomas|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.1
~|~|~|~|VI(c) Unspecified malignant renal tumors|74878093|0-19|All Races|Male and Female|2001|~|~|~
0.2|0.2|0.2|136|VII Hepatic tumors|74878093|0-19|All Races|Male and Female|2001|0.2|0.2|0.2
0.1|0.2|0.1|96|VII(a) Hepatoblastoma|74878093|0-19|All Races|Male and Female|2001|0.1|0.2|0.1
0.0|0.1|0.1|39|VII(b) Hepatic carcinomas|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.1
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74878093|0-19|All Races|Male and Female|2001|~|~|~
0.9|1.0|0.9|700|VIII Malignant bone tumors|74878093|0-19|All Races|Male and Female|2001|0.9|1.0|0.9
0.5|0.6|0.5|385|VIII(a) Osteosarcomas|74878093|0-19|All Races|Male and Female|2001|0.5|0.6|0.5
0.0|0.1|0.0|26|VIII(b) Chondrosarcomas|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.0
0.3|0.4|0.3|248|VIII(c) Ewing tumor and related sarcomas of bone|74878093|0-19|All Races|Male and Female|2001|0.3|0.4|0.3
0.0|0.1|0.0|30|VIII(d) Other specified malignant bone tumors|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.0
~|~|~|~|VIII(e) Unspecified malignant bone tumors|74878093|0-19|All Races|Male and Female|2001|~|~|~
1.0|1.1|1.0|783|X Germ cell, trophoblastic tumors & neoplasms of gonads|74878093|0-19|All Races|Male and Female|2001|1.0|1.1|1.0
0.1|0.2|0.2|121|X(a) Intracranial & intraspinal germ cell tumors|74878093|0-19|All Races|Male and Female|2001|0.1|0.2|0.2
0.1|0.2|0.2|121|X(b) Malignant extracranial & extragonadal germ cell tumors|74878093|0-19|All Races|Male and Female|2001|0.1|0.2|0.2
0.6|0.7|0.7|496|X(c) Malignant gonadal germ cell tumors|74878093|0-19|All Races|Male and Female|2001|0.6|0.7|0.7
0.0|0.0|0.0|25|X(d) Gonadal carcinomas|74878093|0-19|All Races|Male and Female|2001|0.0|0.0|0.0
0.0|0.0|0.0|20|X(e) Other and unspecified malignant gonadal tumors|74878093|0-19|All Races|Male and Female|2001|0.0|0.0|0.0
1.6|1.7|1.7|1238|XI Other malignant epithelial neoplasms and malignant melanomas|74878093|0-19|All Races|Male and Female|2001|1.6|1.7|1.7
0.0|0.0|0.0|16|XI(a) Adrenocortical carcinomas|74878093|0-19|All Races|Male and Female|2001|0.0|0.0|0.0
0.5|0.6|0.6|438|XI(b) Thyroid carcinomas|74878093|0-19|All Races|Male and Female|2001|0.5|0.6|0.6
0.0|0.1|0.1|44|XI(c) Nasopharyngeal carcinomas|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.1
0.5|0.6|0.6|434|XI(d) Malignant melanomas|74878093|0-19|All Races|Male and Female|2001|0.5|0.6|0.6
~|~|~|~|XI(e) Skin carcinomas|74878093|0-19|All Races|Male and Female|2001|~|~|~
0.4|0.5|0.4|302|XI(f) Other and unspecified carcinomas|74878093|0-19|All Races|Male and Female|2001|0.4|0.5|0.4
0.1|0.1|0.1|51|XII Other and unspecified malignant neoplasms|74878093|0-19|All Races|Male and Female|2001|0.1|0.1|0.1
0.0|0.1|0.0|28|XII(a) Other specified malignant tumors|74878093|0-19|All Races|Male and Female|2001|0.0|0.1|0.0
0.0|0.0|0.0|23|XII(b) Other unspecified malignant tumors|74878093|0-19|All Races|Male and Female|2001|0.0|0.0|0.0
16.6|17.2|16.9|12667|All ICCC Groups Combined|74939309|0-19|All Races|Male and Female|2002|16.6|17.2|16.9
4.3|4.6|4.4|3323|I Leukemias, myeloproliferative & myelodysplastic diseases|74939309|0-19|All Races|Male and Female|2002|4.3|4.6|4.4
3.0|3.3|3.1|2350|I(a) Lymphoid leukemias|74939309|0-19|All Races|Male and Female|2002|3.0|3.3|3.1
0.8|0.9|0.8|616|I(b) Acute myeloid leukemias|74939309|0-19|All Races|Male and Female|2002|0.8|0.9|0.8
0.2|0.2|0.2|151|I(c) Chronic myeloproliferative diseases|74939309|0-19|All Races|Male and Female|2002|0.2|0.2|0.2
0.1|0.2|0.2|113|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74939309|0-19|All Races|Male and Female|2002|0.1|0.2|0.2
0.1|0.2|0.1|93|I(e) Unspecified and other specified leukemias|74939309|0-19|All Races|Male and Female|2002|0.1|0.2|0.1
2.3|2.5|2.4|1814|II Lymphomas and reticuloendothelial neoplasms|74939309|0-19|All Races|Male and Female|2002|2.3|2.5|2.4
1.1|1.3|1.2|910|II(a) Hodgkin lymphomas|74939309|0-19|All Races|Male and Female|2002|1.1|1.3|1.2
0.8|0.9|0.8|617|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74939309|0-19|All Races|Male and Female|2002|0.8|0.9|0.8
0.2|0.3|0.3|201|II(c) Burkitt lymphoma|74939309|0-19|All Races|Male and Female|2002|0.2|0.3|0.3
0.1|0.1|0.1|62|II(d) Miscellaneous lymphoreticular neoplasms|74939309|0-19|All Races|Male and Female|2002|0.1|0.1|0.1
0.0|0.0|0.0|24|II(e) Unspecified lymphomas|74939309|0-19|All Races|Male and Female|2002|0.0|0.0|0.0
2.9|3.2|3.1|2284|III CNS and misc intracranial and intraspinal neoplasms|74939309|0-19|All Races|Male and Female|2002|2.9|3.2|3.0
0.3|0.3|0.3|222|III(a) Ependymomas and choroid plexus tumor|74939309|0-19|All Races|Male and Female|2002|0.3|0.3|0.3
1.4|1.6|1.5|1097|III(b) Astrocytomas|74939309|0-19|All Races|Male and Female|2002|1.4|1.6|1.5
0.6|0.7|0.6|477|III(c) Intracranial and intraspinal embryonal tumors|74939309|0-19|All Races|Male and Female|2002|0.6|0.7|0.6
0.5|0.6|0.5|406|III(d) Other gliomas|74939309|0-19|All Races|Male and Female|2002|0.5|0.6|0.5
0.1|0.1|0.1|54|III(e) Other specified intracranial & intraspinal neoplasms|74939309|0-19|All Races|Male and Female|2002|0.1|0.1|0.1
0.0|0.1|0.0|28|III(f) Unspecified intracranial and intraspinal neoplasms|74939309|0-19|All Races|Male and Female|2002|0.0|0.1|0.0
0.8|0.9|0.8|626|IV Neuroblastoma and other peripheral nervous cell tumors|74939309|0-19|All Races|Male and Female|2002|0.8|0.9|0.8
0.7|0.9|0.8|611|IV(a) Neuroblastoma and ganglioneuroblastoma|74939309|0-19|All Races|Male and Female|2002|0.8|0.9|0.8
~|~|~|~|IV(b) Other peripheral nervous cell tumors|74939309|0-19|All Races|Male and Female|2002|~|~|~
1.1|1.3|1.2|885|IX Soft tissue and other extraosseous sarcomas|74939309|0-19|All Races|Male and Female|2002|1.1|1.3|1.2
0.4|0.5|0.5|367|IX(a) Rhabdomyosarcomas|74939309|0-19|All Races|Male and Female|2002|0.4|0.5|0.5
0.1|0.1|0.1|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74939309|0-19|All Races|Male and Female|2002|0.1|0.1|0.1
~|~|~|~|IX(c) Kaposi sarcoma|74939309|0-19|All Races|Male and Female|2002|~|~|~
0.4|0.5|0.5|354|IX(d) Other specified soft tissue sarcomas|74939309|0-19|All Races|Male and Female|2002|0.4|0.5|0.5
0.1|0.1|0.1|74|IX(e) Unspecified soft tissue sarcomas|74939309|0-19|All Races|Male and Female|2002|0.1|0.1|0.1
0.0|0.1|0.0|28|Not classified by ICCC|74939309|0-19|All Races|Male and Female|2002|0.0|0.1|0.0
0.2|0.3|0.3|209|V Retinoblastoma|74939309|0-19|All Races|Male and Female|2002|0.2|0.3|0.3
0.6|0.7|0.6|485|VI Renal tumors|74939309|0-19|All Races|Male and Female|2002|0.6|0.7|0.6
0.6|0.7|0.6|453|VI(a) Nephroblastoma and other nonepithelial renal tumors|74939309|0-19|All Races|Male and Female|2002|0.6|0.7|0.6
0.0|0.1|0.0|31|VI(b) Renal carcinomas|74939309|0-19|All Races|Male and Female|2002|0.0|0.1|0.0
~|~|~|~|VI(c) Unspecified malignant renal tumors|74939309|0-19|All Races|Male and Female|2002|~|~|~
0.1|0.2|0.2|125|VII Hepatic tumors|74939309|0-19|All Races|Male and Female|2002|0.1|0.2|0.2
0.1|0.1|0.1|87|VII(a) Hepatoblastoma|74939309|0-19|All Races|Male and Female|2002|0.1|0.1|0.1
0.0|0.1|0.0|37|VII(b) Hepatic carcinomas|74939309|0-19|All Races|Male and Female|2002|0.0|0.1|0.0
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74939309|0-19|All Races|Male and Female|2002|~|~|~
0.8|1.0|0.9|683|VIII Malignant bone tumors|74939309|0-19|All Races|Male and Female|2002|0.8|1.0|0.9
0.4|0.5|0.5|372|VIII(a) Osteosarcomas|74939309|0-19|All Races|Male and Female|2002|0.4|0.5|0.5
0.0|0.1|0.0|35|VIII(b) Chondrosarcomas|74939309|0-19|All Races|Male and Female|2002|0.0|0.1|0.0
0.3|0.3|0.3|226|VIII(c) Ewing tumor and related sarcomas of bone|74939309|0-19|All Races|Male and Female|2002|0.3|0.3|0.3
0.0|0.1|0.1|39|VIII(d) Other specified malignant bone tumors|74939309|0-19|All Races|Male and Female|2002|0.0|0.1|0.1
~|~|~|~|VIII(e) Unspecified malignant bone tumors|74939309|0-19|All Races|Male and Female|2002|~|~|~
1.0|1.2|1.1|841|X Germ cell, trophoblastic tumors & neoplasms of gonads|74939309|0-19|All Races|Male and Female|2002|1.0|1.2|1.1
0.1|0.2|0.2|128|X(a) Intracranial & intraspinal germ cell tumors|74939309|0-19|All Races|Male and Female|2002|0.1|0.2|0.2
0.1|0.2|0.2|123|X(b) Malignant extracranial & extragonadal germ cell tumors|74939309|0-19|All Races|Male and Female|2002|0.1|0.2|0.2
0.7|0.8|0.7|548|X(c) Malignant gonadal germ cell tumors|74939309|0-19|All Races|Male and Female|2002|0.7|0.8|0.7
0.0|0.0|0.0|20|X(d) Gonadal carcinomas|74939309|0-19|All Races|Male and Female|2002|0.0|0.0|0.0
0.0|0.0|0.0|22|X(e) Other and unspecified malignant gonadal tumors|74939309|0-19|All Races|Male and Female|2002|0.0|0.0|0.0
1.6|1.8|1.7|1306|XI Other malignant epithelial neoplasms and malignant melanomas|74939309|0-19|All Races|Male and Female|2002|1.6|1.8|1.7
0.0|0.0|0.0|18|XI(a) Adrenocortical carcinomas|74939309|0-19|All Races|Male and Female|2002|0.0|0.0|0.0
0.5|0.6|0.6|427|XI(b) Thyroid carcinomas|74939309|0-19|All Races|Male and Female|2002|0.5|0.6|0.6
0.0|0.1|0.1|48|XI(c) Nasopharyngeal carcinomas|74939309|0-19|All Races|Male and Female|2002|0.0|0.1|0.1
0.6|0.7|0.7|503|XI(d) Malignant melanomas|74939309|0-19|All Races|Male and Female|2002|0.6|0.7|0.7
~|~|~|~|XI(e) Skin carcinomas|74939309|0-19|All Races|Male and Female|2002|~|~|~
0.4|0.4|0.4|302|XI(f) Other and unspecified carcinomas|74939309|0-19|All Races|Male and Female|2002|0.4|0.5|0.4
0.1|0.1|0.1|58|XII Other and unspecified malignant neoplasms|74939309|0-19|All Races|Male and Female|2002|0.1|0.1|0.1
0.0|0.1|0.0|35|XII(a) Other specified malignant tumors|74939309|0-19|All Races|Male and Female|2002|0.0|0.1|0.0
0.0|0.0|0.0|23|XII(b) Other unspecified malignant tumors|74939309|0-19|All Races|Male and Female|2002|0.0|0.0|0.0
16.8|17.0|16.9|62628|All ICCC Groups Combined|368492797|0-19|All Races|Male and Female|2002-2006|16.8|17.1|16.9
4.3|4.5|4.4|16309|I Leukemias, myeloproliferative & myelodysplastic diseases|368492797|0-19|All Races|Male and Female|2002-2006|4.4|4.5|4.5
3.1|3.2|3.2|11629|I(a) Lymphoid leukemias|368492797|0-19|All Races|Male and Female|2002-2006|3.1|3.2|3.2
0.8|0.8|0.8|2934|I(b) Acute myeloid leukemias|368492797|0-19|All Races|Male and Female|2002-2006|0.8|0.8|0.8
0.2|0.2|0.2|734|I(c) Chronic myeloproliferative diseases|368492797|0-19|All Races|Male and Female|2002-2006|0.2|0.2|0.2
0.1|0.2|0.1|549|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.2|0.1
0.1|0.1|0.1|463|I(e) Unspecified and other specified leukemias|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.1|0.1
2.4|2.5|2.5|9154|II Lymphomas and reticuloendothelial neoplasms|368492797|0-19|All Races|Male and Female|2002-2006|2.4|2.5|2.5
1.2|1.3|1.2|4597|II(a) Hodgkin lymphomas|368492797|0-19|All Races|Male and Female|2002-2006|1.2|1.3|1.2
0.8|0.9|0.9|3158|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|368492797|0-19|All Races|Male and Female|2002-2006|0.8|0.9|0.9
0.2|0.3|0.3|928|II(c) Burkitt lymphoma|368492797|0-19|All Races|Male and Female|2002-2006|0.2|0.3|0.2
0.1|0.1|0.1|355|II(d) Miscellaneous lymphoreticular neoplasms|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.1|0.1
0.0|0.0|0.0|116|II(e) Unspecified lymphomas|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
2.9|3.0|3.0|10988|III CNS and misc intracranial and intraspinal neoplasms|368492797|0-19|All Races|Male and Female|2002-2006|2.9|3.0|3.0
0.3|0.3|0.3|996|III(a) Ependymomas and choroid plexus tumor|368492797|0-19|All Races|Male and Female|2002-2006|0.3|0.3|0.3
1.4|1.5|1.5|5451|III(b) Astrocytomas|368492797|0-19|All Races|Male and Female|2002-2006|1.4|1.5|1.5
0.6|0.6|0.6|2253|III(c) Intracranial and intraspinal embryonal tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.6|0.6|0.6
0.5|0.5|0.5|1859|III(d) Other gliomas|368492797|0-19|All Races|Male and Female|2002-2006|0.5|0.5|0.5
0.1|0.1|0.1|251|III(e) Other specified intracranial & intraspinal neoplasms|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.1|0.1
0.0|0.1|0.0|178|III(f) Unspecified intracranial and intraspinal neoplasms|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.1|0.0
0.8|0.8|0.8|3057|IV Neuroblastoma and other peripheral nervous cell tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.8|0.9|0.8
0.8|0.8|0.8|2986|IV(a) Neuroblastoma and ganglioneuroblastoma|368492797|0-19|All Races|Male and Female|2002-2006|0.8|0.8|0.8
0.0|0.0|0.0|71|IV(b) Other peripheral nervous cell tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
1.2|1.2|1.2|4424|IX Soft tissue and other extraosseous sarcomas|368492797|0-19|All Races|Male and Female|2002-2006|1.2|1.2|1.2
0.4|0.5|0.5|1726|IX(a) Rhabdomyosarcomas|368492797|0-19|All Races|Male and Female|2002-2006|0.4|0.5|0.5
0.1|0.1|0.1|485|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.1|0.1
~|~|~|~|IX(c) Kaposi sarcoma|368492797|0-19|All Races|Male and Female|2002-2006|~|~|~
0.5|0.5|0.5|1778|IX(d) Other specified soft tissue sarcomas|368492797|0-19|All Races|Male and Female|2002-2006|0.5|0.5|0.5
0.1|0.1|0.1|422|IX(e) Unspecified soft tissue sarcomas|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.1|0.1
0.0|0.0|0.0|130|Not classified by ICCC|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
0.3|0.3|0.3|1098|V Retinoblastoma|368492797|0-19|All Races|Male and Female|2002-2006|0.3|0.3|0.3
0.6|0.7|0.7|2432|VI Renal tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.6|0.7|0.7
0.6|0.6|0.6|2211|VI(a) Nephroblastoma and other nonepithelial renal tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.6|0.6|0.6
0.0|0.1|0.1|205|VI(b) Renal carcinomas|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.1|0.1
0.0|0.0|0.0|16|VI(c) Unspecified malignant renal tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
0.2|0.2|0.2|786|VII Hepatic tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.2|0.2|0.2
0.1|0.2|0.1|556|VII(a) Hepatoblastoma|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.2|0.2
0.1|0.1|0.1|217|VII(b) Hepatic carcinomas|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.1|0.1
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|368492797|0-19|All Races|Male and Female|2002-2006|~|~|~
0.9|0.9|0.9|3315|VIII Malignant bone tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.9|0.9|0.9
0.5|0.5|0.5|1910|VIII(a) Osteosarcomas|368492797|0-19|All Races|Male and Female|2002-2006|0.5|0.5|0.5
0.0|0.0|0.0|126|VIII(b) Chondrosarcomas|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
0.3|0.3|0.3|1041|VIII(c) Ewing tumor and related sarcomas of bone|368492797|0-19|All Races|Male and Female|2002-2006|0.3|0.3|0.3
0.0|0.1|0.0|170|VIII(d) Other specified malignant bone tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.1|0.0
0.0|0.0|0.0|68|VIII(e) Unspecified malignant bone tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
1.1|1.1|1.1|4074|X Germ cell, trophoblastic tumors & neoplasms of gonads|368492797|0-19|All Races|Male and Female|2002-2006|1.1|1.2|1.1
0.1|0.2|0.2|585|X(a) Intracranial & intraspinal germ cell tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.2|0.2|0.2
0.1|0.2|0.1|556|X(b) Malignant extracranial & extragonadal germ cell tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.2|0.2
0.7|0.7|0.7|2674|X(c) Malignant gonadal germ cell tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.7|0.8|0.7
0.0|0.0|0.0|142|X(d) Gonadal carcinomas|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
0.0|0.0|0.0|117|X(e) Other and unspecified malignant gonadal tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
1.7|1.8|1.8|6544|XI Other malignant epithelial neoplasms and malignant melanomas|368492797|0-19|All Races|Male and Female|2002-2006|1.7|1.8|1.7
0.0|0.0|0.0|77|XI(a) Adrenocortical carcinomas|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
0.6|0.7|0.6|2353|XI(b) Thyroid carcinomas|368492797|0-19|All Races|Male and Female|2002-2006|0.6|0.7|0.6
0.1|0.1|0.1|221|XI(c) Nasopharyngeal carcinomas|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.1|0.1
0.6|0.7|0.6|2326|XI(d) Malignant melanomas|368492797|0-19|All Races|Male and Female|2002-2006|0.6|0.6|0.6
0.0|0.0|0.0|31|XI(e) Skin carcinomas|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
0.4|0.4|0.4|1536|XI(f) Other and unspecified carcinomas|368492797|0-19|All Races|Male and Female|2002-2006|0.4|0.4|0.4
0.1|0.1|0.1|317|XII Other and unspecified malignant neoplasms|368492797|0-19|All Races|Male and Female|2002-2006|0.1|0.1|0.1
0.0|0.0|0.0|158|XII(a) Other specified malignant tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
0.0|0.0|0.0|159|XII(b) Other unspecified malignant tumors|368492797|0-19|All Races|Male and Female|2002-2006|0.0|0.0|0.0
16.3|16.8|16.5|12960|All ICCC Groups Combined|78112034|0-19|All Races|Male and Female|2003|16.3|16.9|16.6
4.1|4.4|4.3|3336|I Leukemias, myeloproliferative & myelodysplastic diseases|78112034|0-19|All Races|Male and Female|2003|4.1|4.4|4.3
2.9|3.2|3.0|2365|I(a) Lymphoid leukemias|78112034|0-19|All Races|Male and Female|2003|2.9|3.2|3.0
0.7|0.8|0.8|603|I(b) Acute myeloid leukemias|78112034|0-19|All Races|Male and Female|2003|0.7|0.8|0.8
0.2|0.2|0.2|161|I(c) Chronic myeloproliferative diseases|78112034|0-19|All Races|Male and Female|2003|0.2|0.2|0.2
0.1|0.2|0.2|127|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78112034|0-19|All Races|Male and Female|2003|0.1|0.2|0.2
0.1|0.1|0.1|80|I(e) Unspecified and other specified leukemias|78112034|0-19|All Races|Male and Female|2003|0.1|0.1|0.1
2.3|2.5|2.4|1881|II Lymphomas and reticuloendothelial neoplasms|78112034|0-19|All Races|Male and Female|2003|2.3|2.5|2.4
1.2|1.3|1.2|970|II(a) Hodgkin lymphomas|78112034|0-19|All Races|Male and Female|2003|1.2|1.3|1.2
0.7|0.9|0.8|634|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78112034|0-19|All Races|Male and Female|2003|0.7|0.9|0.8
0.2|0.3|0.3|198|II(c) Burkitt lymphoma|78112034|0-19|All Races|Male and Female|2003|0.2|0.3|0.3
0.1|0.1|0.1|62|II(d) Miscellaneous lymphoreticular neoplasms|78112034|0-19|All Races|Male and Female|2003|0.1|0.1|0.1
0.0|0.0|0.0|17|II(e) Unspecified lymphomas|78112034|0-19|All Races|Male and Female|2003|0.0|0.0|0.0
2.8|3.1|2.9|2296|III CNS and misc intracranial and intraspinal neoplasms|78112034|0-19|All Races|Male and Female|2003|2.8|3.1|2.9
0.2|0.3|0.2|182|III(a) Ependymomas and choroid plexus tumor|78112034|0-19|All Races|Male and Female|2003|0.2|0.3|0.2
1.4|1.6|1.5|1153|III(b) Astrocytomas|78112034|0-19|All Races|Male and Female|2003|1.4|1.6|1.5
0.6|0.7|0.6|471|III(c) Intracranial and intraspinal embryonal tumors|78112034|0-19|All Races|Male and Female|2003|0.5|0.7|0.6
0.5|0.6|0.5|404|III(d) Other gliomas|78112034|0-19|All Races|Male and Female|2003|0.5|0.6|0.5
0.1|0.1|0.1|56|III(e) Other specified intracranial & intraspinal neoplasms|78112034|0-19|All Races|Male and Female|2003|0.1|0.1|0.1
0.0|0.1|0.0|30|III(f) Unspecified intracranial and intraspinal neoplasms|78112034|0-19|All Races|Male and Female|2003|0.0|0.1|0.0
0.7|0.9|0.8|627|IV Neuroblastoma and other peripheral nervous cell tumors|78112034|0-19|All Races|Male and Female|2003|0.7|0.9|0.8
0.7|0.8|0.8|616|IV(a) Neuroblastoma and ganglioneuroblastoma|78112034|0-19|All Races|Male and Female|2003|0.7|0.9|0.8
~|~|~|~|IV(b) Other peripheral nervous cell tumors|78112034|0-19|All Races|Male and Female|2003|~|~|~
1.1|1.3|1.2|954|IX Soft tissue and other extraosseous sarcomas|78112034|0-19|All Races|Male and Female|2003|1.1|1.3|1.2
0.4|0.5|0.5|383|IX(a) Rhabdomyosarcomas|78112034|0-19|All Races|Male and Female|2003|0.4|0.5|0.5
0.1|0.2|0.1|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78112034|0-19|All Races|Male and Female|2003|0.1|0.2|0.1
~|~|~|~|IX(c) Kaposi sarcoma|78112034|0-19|All Races|Male and Female|2003|~|~|~
0.4|0.5|0.5|360|IX(d) Other specified soft tissue sarcomas|78112034|0-19|All Races|Male and Female|2003|0.4|0.5|0.5
0.1|0.2|0.1|99|IX(e) Unspecified soft tissue sarcomas|78112034|0-19|All Races|Male and Female|2003|0.1|0.2|0.1
0.0|0.0|0.0|25|Not classified by ICCC|78112034|0-19|All Races|Male and Female|2003|0.0|0.0|0.0
0.3|0.3|0.3|232|V Retinoblastoma|78112034|0-19|All Races|Male and Female|2003|0.3|0.3|0.3
0.6|0.7|0.7|509|VI Renal tumors|78112034|0-19|All Races|Male and Female|2003|0.6|0.7|0.7
0.5|0.6|0.6|464|VI(a) Nephroblastoma and other nonepithelial renal tumors|78112034|0-19|All Races|Male and Female|2003|0.5|0.7|0.6
0.0|0.1|0.1|41|VI(b) Renal carcinomas|78112034|0-19|All Races|Male and Female|2003|0.0|0.1|0.1
~|~|~|~|VI(c) Unspecified malignant renal tumors|78112034|0-19|All Races|Male and Female|2003|~|~|~
0.2|0.2|0.2|170|VII Hepatic tumors|78112034|0-19|All Races|Male and Female|2003|0.2|0.3|0.2
0.1|0.2|0.2|122|VII(a) Hepatoblastoma|78112034|0-19|All Races|Male and Female|2003|0.1|0.2|0.2
0.0|0.1|0.1|48|VII(b) Hepatic carcinomas|78112034|0-19|All Races|Male and Female|2003|0.0|0.1|0.1
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78112034|0-19|All Races|Male and Female|2003|~|~|~
0.8|0.9|0.9|683|VIII Malignant bone tumors|78112034|0-19|All Races|Male and Female|2003|0.8|0.9|0.9
0.5|0.6|0.5|419|VIII(a) Osteosarcomas|78112034|0-19|All Races|Male and Female|2003|0.5|0.6|0.5
0.0|0.0|0.0|19|VIII(b) Chondrosarcomas|78112034|0-19|All Races|Male and Female|2003|0.0|0.0|0.0
0.2|0.3|0.3|202|VIII(c) Ewing tumor and related sarcomas of bone|78112034|0-19|All Races|Male and Female|2003|0.2|0.3|0.3
0.0|0.0|0.0|26|VIII(d) Other specified malignant bone tumors|78112034|0-19|All Races|Male and Female|2003|0.0|0.0|0.0
0.0|0.0|0.0|17|VIII(e) Unspecified malignant bone tumors|78112034|0-19|All Races|Male and Female|2003|0.0|0.0|0.0
1.0|1.1|1.0|805|X Germ cell, trophoblastic tumors & neoplasms of gonads|78112034|0-19|All Races|Male and Female|2003|1.0|1.1|1.0
0.1|0.2|0.1|109|X(a) Intracranial & intraspinal germ cell tumors|78112034|0-19|All Races|Male and Female|2003|0.1|0.2|0.1
0.1|0.2|0.1|115|X(b) Malignant extracranial & extragonadal germ cell tumors|78112034|0-19|All Races|Male and Female|2003|0.1|0.2|0.1
0.6|0.7|0.7|527|X(c) Malignant gonadal germ cell tumors|78112034|0-19|All Races|Male and Female|2003|0.6|0.7|0.7
0.0|0.0|0.0|24|X(d) Gonadal carcinomas|78112034|0-19|All Races|Male and Female|2003|0.0|0.0|0.0
0.0|0.1|0.0|30|X(e) Other and unspecified malignant gonadal tumors|78112034|0-19|All Races|Male and Female|2003|0.0|0.1|0.0
1.6|1.8|1.7|1364|XI Other malignant epithelial neoplasms and malignant melanomas|78112034|0-19|All Races|Male and Female|2003|1.7|1.8|1.7
0.0|0.0|0.0|20|XI(a) Adrenocortical carcinomas|78112034|0-19|All Races|Male and Female|2003|0.0|0.0|0.0
0.6|0.7|0.6|476|XI(b) Thyroid carcinomas|78112034|0-19|All Races|Male and Female|2003|0.6|0.7|0.6
0.1|0.1|0.1|54|XI(c) Nasopharyngeal carcinomas|78112034|0-19|All Races|Male and Female|2003|0.1|0.1|0.1
0.6|0.7|0.6|474|XI(d) Malignant melanomas|78112034|0-19|All Races|Male and Female|2003|0.6|0.7|0.6
~|~|~|~|XI(e) Skin carcinomas|78112034|0-19|All Races|Male and Female|2003|~|~|~
0.4|0.5|0.4|332|XI(f) Other and unspecified carcinomas|78112034|0-19|All Races|Male and Female|2003|0.4|0.5|0.4
0.1|0.1|0.1|78|XII Other and unspecified malignant neoplasms|78112034|0-19|All Races|Male and Female|2003|0.1|0.1|0.1
0.0|0.1|0.0|36|XII(a) Other specified malignant tumors|78112034|0-19|All Races|Male and Female|2003|0.0|0.1|0.0
0.0|0.1|0.1|42|XII(b) Other unspecified malignant tumors|78112034|0-19|All Races|Male and Female|2003|0.0|0.1|0.1
16.9|17.5|17.2|13823|All ICCC Groups Combined|79979457|0-19|All Races|Male and Female|2004|17.0|17.6|17.3
4.4|4.7|4.5|3638|I Leukemias, myeloproliferative & myelodysplastic diseases|79979457|0-19|All Races|Male and Female|2004|4.4|4.7|4.5
3.1|3.4|3.3|2612|I(a) Lymphoid leukemias|79979457|0-19|All Races|Male and Female|2004|3.1|3.4|3.3
0.8|0.9|0.8|661|I(b) Acute myeloid leukemias|79979457|0-19|All Races|Male and Female|2004|0.8|0.9|0.8
0.2|0.2|0.2|152|I(c) Chronic myeloproliferative diseases|79979457|0-19|All Races|Male and Female|2004|0.2|0.2|0.2
0.1|0.2|0.1|110|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|79979457|0-19|All Races|Male and Female|2004|0.1|0.2|0.1
0.1|0.2|0.1|103|I(e) Unspecified and other specified leukemias|79979457|0-19|All Races|Male and Female|2004|0.1|0.2|0.1
2.3|2.5|2.4|1937|II Lymphomas and reticuloendothelial neoplasms|79979457|0-19|All Races|Male and Female|2004|2.3|2.5|2.4
1.1|1.3|1.2|954|II(a) Hodgkin lymphomas|79979457|0-19|All Races|Male and Female|2004|1.1|1.3|1.2
0.8|0.9|0.9|683|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|79979457|0-19|All Races|Male and Female|2004|0.8|0.9|0.9
0.2|0.3|0.2|187|II(c) Burkitt lymphoma|79979457|0-19|All Races|Male and Female|2004|0.2|0.3|0.2
0.1|0.1|0.1|81|II(d) Miscellaneous lymphoreticular neoplasms|79979457|0-19|All Races|Male and Female|2004|0.1|0.1|0.1
0.0|0.1|0.0|32|II(e) Unspecified lymphomas|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.0
3.0|3.2|3.1|2464|III CNS and misc intracranial and intraspinal neoplasms|79979457|0-19|All Races|Male and Female|2004|3.0|3.2|3.1
0.2|0.3|0.3|219|III(a) Ependymomas and choroid plexus tumor|79979457|0-19|All Races|Male and Female|2004|0.2|0.3|0.3
1.5|1.6|1.6|1240|III(b) Astrocytomas|79979457|0-19|All Races|Male and Female|2004|1.5|1.6|1.6
0.6|0.7|0.6|516|III(c) Intracranial and intraspinal embryonal tumors|79979457|0-19|All Races|Male and Female|2004|0.6|0.7|0.6
0.4|0.5|0.5|390|III(d) Other gliomas|79979457|0-19|All Races|Male and Female|2004|0.4|0.5|0.5
0.1|0.1|0.1|57|III(e) Other specified intracranial & intraspinal neoplasms|79979457|0-19|All Races|Male and Female|2004|0.1|0.1|0.1
0.0|0.1|0.1|42|III(f) Unspecified intracranial and intraspinal neoplasms|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.1
0.8|0.9|0.8|677|IV Neuroblastoma and other peripheral nervous cell tumors|79979457|0-19|All Races|Male and Female|2004|0.8|0.9|0.8
0.7|0.9|0.8|655|IV(a) Neuroblastoma and ganglioneuroblastoma|79979457|0-19|All Races|Male and Female|2004|0.8|0.9|0.8
0.0|0.0|0.0|22|IV(b) Other peripheral nervous cell tumors|79979457|0-19|All Races|Male and Female|2004|0.0|0.0|0.0
1.1|1.3|1.2|961|IX Soft tissue and other extraosseous sarcomas|79979457|0-19|All Races|Male and Female|2004|1.1|1.3|1.2
0.4|0.5|0.4|349|IX(a) Rhabdomyosarcomas|79979457|0-19|All Races|Male and Female|2004|0.4|0.5|0.4
0.1|0.2|0.1|105|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|79979457|0-19|All Races|Male and Female|2004|0.1|0.2|0.1
~|~|~|~|IX(c) Kaposi sarcoma|79979457|0-19|All Races|Male and Female|2004|~|~|~
0.5|0.6|0.5|406|IX(d) Other specified soft tissue sarcomas|79979457|0-19|All Races|Male and Female|2004|0.5|0.6|0.5
0.1|0.1|0.1|98|IX(e) Unspecified soft tissue sarcomas|79979457|0-19|All Races|Male and Female|2004|0.1|0.1|0.1
0.0|0.1|0.0|31|Not classified by ICCC|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.0
0.3|0.3|0.3|254|V Retinoblastoma|79979457|0-19|All Races|Male and Female|2004|0.3|0.4|0.3
0.6|0.7|0.6|521|VI Renal tumors|79979457|0-19|All Races|Male and Female|2004|0.6|0.7|0.7
0.5|0.6|0.6|474|VI(a) Nephroblastoma and other nonepithelial renal tumors|79979457|0-19|All Races|Male and Female|2004|0.5|0.6|0.6
0.0|0.1|0.1|45|VI(b) Renal carcinomas|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.1
~|~|~|~|VI(c) Unspecified malignant renal tumors|79979457|0-19|All Races|Male and Female|2004|~|~|~
0.2|0.3|0.2|194|VII Hepatic tumors|79979457|0-19|All Races|Male and Female|2004|0.2|0.3|0.2
0.1|0.2|0.2|142|VII(a) Hepatoblastoma|79979457|0-19|All Races|Male and Female|2004|0.1|0.2|0.2
0.0|0.1|0.1|47|VII(b) Hepatic carcinomas|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.1
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|79979457|0-19|All Races|Male and Female|2004|~|~|~
0.8|1.0|0.9|723|VIII Malignant bone tumors|79979457|0-19|All Races|Male and Female|2004|0.8|1.0|0.9
0.5|0.6|0.5|418|VIII(a) Osteosarcomas|79979457|0-19|All Races|Male and Female|2004|0.5|0.6|0.5
0.0|0.1|0.0|40|VIII(b) Chondrosarcomas|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.1
0.2|0.3|0.3|215|VIII(c) Ewing tumor and related sarcomas of bone|79979457|0-19|All Races|Male and Female|2004|0.2|0.3|0.3
0.0|0.1|0.0|37|VIII(d) Other specified malignant bone tumors|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.0
~|~|~|~|VIII(e) Unspecified malignant bone tumors|79979457|0-19|All Races|Male and Female|2004|~|~|~
1.0|1.2|1.1|902|X Germ cell, trophoblastic tumors & neoplasms of gonads|79979457|0-19|All Races|Male and Female|2004|1.1|1.2|1.1
0.2|0.2|0.2|146|X(a) Intracranial & intraspinal germ cell tumors|79979457|0-19|All Races|Male and Female|2004|0.2|0.2|0.2
0.1|0.2|0.1|106|X(b) Malignant extracranial & extragonadal germ cell tumors|79979457|0-19|All Races|Male and Female|2004|0.1|0.2|0.1
0.7|0.8|0.7|595|X(c) Malignant gonadal germ cell tumors|79979457|0-19|All Races|Male and Female|2004|0.7|0.8|0.7
0.0|0.1|0.0|31|X(d) Gonadal carcinomas|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.0
0.0|0.0|0.0|24|X(e) Other and unspecified malignant gonadal tumors|79979457|0-19|All Races|Male and Female|2004|0.0|0.0|0.0
1.7|1.9|1.8|1454|XI Other malignant epithelial neoplasms and malignant melanomas|79979457|0-19|All Races|Male and Female|2004|1.7|1.9|1.8
0.0|0.0|0.0|17|XI(a) Adrenocortical carcinomas|79979457|0-19|All Races|Male and Female|2004|0.0|0.0|0.0
0.6|0.7|0.7|538|XI(b) Thyroid carcinomas|79979457|0-19|All Races|Male and Female|2004|0.6|0.7|0.7
0.0|0.1|0.1|44|XI(c) Nasopharyngeal carcinomas|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.1
0.6|0.7|0.7|532|XI(d) Malignant melanomas|79979457|0-19|All Races|Male and Female|2004|0.6|0.7|0.7
~|~|~|~|XI(e) Skin carcinomas|79979457|0-19|All Races|Male and Female|2004|~|~|~
0.3|0.4|0.4|314|XI(f) Other and unspecified carcinomas|79979457|0-19|All Races|Male and Female|2004|0.4|0.4|0.4
0.1|0.1|0.1|67|XII Other and unspecified malignant neoplasms|79979457|0-19|All Races|Male and Female|2004|0.1|0.1|0.1
0.0|0.1|0.0|31|XII(a) Other specified malignant tumors|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.0
0.0|0.1|0.0|36|XII(b) Other unspecified malignant tumors|79979457|0-19|All Races|Male and Female|2004|0.0|0.1|0.0
16.5|17.1|16.8|13598|All ICCC Groups Combined|80201013|0-19|All Races|Male and Female|2005|16.7|17.2|17.0
4.2|4.5|4.3|3488|I Leukemias, myeloproliferative & myelodysplastic diseases|80201013|0-19|All Races|Male and Female|2005|4.2|4.5|4.3
3.0|3.3|3.1|2524|I(a) Lymphoid leukemias|80201013|0-19|All Races|Male and Female|2005|3.0|3.3|3.1
0.7|0.8|0.7|598|I(b) Acute myeloid leukemias|80201013|0-19|All Races|Male and Female|2005|0.7|0.8|0.7
0.2|0.2|0.2|148|I(c) Chronic myeloproliferative diseases|80201013|0-19|All Races|Male and Female|2005|0.2|0.2|0.2
0.1|0.2|0.1|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80201013|0-19|All Races|Male and Female|2005|0.1|0.2|0.1
0.1|0.2|0.1|100|I(e) Unspecified and other specified leukemias|80201013|0-19|All Races|Male and Female|2005|0.1|0.2|0.1
2.5|2.7|2.6|2069|II Lymphomas and reticuloendothelial neoplasms|80201013|0-19|All Races|Male and Female|2005|2.5|2.7|2.6
1.2|1.3|1.3|1027|II(a) Hodgkin lymphomas|80201013|0-19|All Races|Male and Female|2005|1.2|1.4|1.3
0.8|1.0|0.9|723|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80201013|0-19|All Races|Male and Female|2005|0.8|1.0|0.9
0.2|0.3|0.2|199|II(c) Burkitt lymphoma|80201013|0-19|All Races|Male and Female|2005|0.2|0.3|0.2
0.1|0.1|0.1|93|II(d) Miscellaneous lymphoreticular neoplasms|80201013|0-19|All Races|Male and Female|2005|0.1|0.1|0.1
0.0|0.0|0.0|27|II(e) Unspecified lymphomas|80201013|0-19|All Races|Male and Female|2005|0.0|0.0|0.0
2.8|3.0|2.9|2304|III CNS and misc intracranial and intraspinal neoplasms|80201013|0-19|All Races|Male and Female|2005|2.8|3.0|2.9
0.2|0.3|0.3|227|III(a) Ependymomas and choroid plexus tumor|80201013|0-19|All Races|Male and Female|2005|0.2|0.3|0.3
1.4|1.5|1.5|1164|III(b) Astrocytomas|80201013|0-19|All Races|Male and Female|2005|1.4|1.5|1.5
0.5|0.6|0.6|458|III(c) Intracranial and intraspinal embryonal tumors|80201013|0-19|All Races|Male and Female|2005|0.5|0.6|0.6
0.4|0.5|0.5|366|III(d) Other gliomas|80201013|0-19|All Races|Male and Female|2005|0.4|0.5|0.5
0.0|0.1|0.1|52|III(e) Other specified intracranial & intraspinal neoplasms|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.1
0.0|0.1|0.0|37|III(f) Unspecified intracranial and intraspinal neoplasms|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.0
0.8|0.9|0.9|708|IV Neuroblastoma and other peripheral nervous cell tumors|80201013|0-19|All Races|Male and Female|2005|0.8|1.0|0.9
0.8|0.9|0.8|695|IV(a) Neuroblastoma and ganglioneuroblastoma|80201013|0-19|All Races|Male and Female|2005|0.8|0.9|0.9
~|~|~|~|IV(b) Other peripheral nervous cell tumors|80201013|0-19|All Races|Male and Female|2005|~|~|~
1.1|1.3|1.2|970|IX Soft tissue and other extraosseous sarcomas|80201013|0-19|All Races|Male and Female|2005|1.1|1.3|1.2
0.4|0.5|0.5|383|IX(a) Rhabdomyosarcomas|80201013|0-19|All Races|Male and Female|2005|0.4|0.5|0.5
0.1|0.2|0.1|107|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80201013|0-19|All Races|Male and Female|2005|0.1|0.2|0.1
~|~|~|~|IX(c) Kaposi sarcoma|80201013|0-19|All Races|Male and Female|2005|~|~|~
0.4|0.5|0.5|389|IX(d) Other specified soft tissue sarcomas|80201013|0-19|All Races|Male and Female|2005|0.4|0.5|0.5
0.1|0.1|0.1|87|IX(e) Unspecified soft tissue sarcomas|80201013|0-19|All Races|Male and Female|2005|0.1|0.1|0.1
0.0|0.0|0.0|28|Not classified by ICCC|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.0
0.2|0.3|0.3|228|V Retinoblastoma|80201013|0-19|All Races|Male and Female|2005|0.2|0.3|0.3
0.6|0.7|0.6|526|VI Renal tumors|80201013|0-19|All Races|Male and Female|2005|0.6|0.7|0.7
0.5|0.6|0.6|475|VI(a) Nephroblastoma and other nonepithelial renal tumors|80201013|0-19|All Races|Male and Female|2005|0.5|0.6|0.6
0.0|0.1|0.1|48|VI(b) Renal carcinomas|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.1
~|~|~|~|VI(c) Unspecified malignant renal tumors|80201013|0-19|All Races|Male and Female|2005|~|~|~
0.2|0.2|0.2|161|VII Hepatic tumors|80201013|0-19|All Races|Male and Female|2005|0.2|0.2|0.2
0.1|0.2|0.1|113|VII(a) Hepatoblastoma|80201013|0-19|All Races|Male and Female|2005|0.1|0.2|0.1
0.0|0.1|0.1|46|VII(b) Hepatic carcinomas|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.1
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80201013|0-19|All Races|Male and Female|2005|~|~|~
0.8|0.9|0.9|704|VIII Malignant bone tumors|80201013|0-19|All Races|Male and Female|2005|0.8|0.9|0.9
0.4|0.5|0.5|398|VIII(a) Osteosarcomas|80201013|0-19|All Races|Male and Female|2005|0.4|0.5|0.5
0.0|0.0|0.0|20|VIII(b) Chondrosarcomas|80201013|0-19|All Races|Male and Female|2005|0.0|0.0|0.0
0.3|0.3|0.3|237|VIII(c) Ewing tumor and related sarcomas of bone|80201013|0-19|All Races|Male and Female|2005|0.3|0.3|0.3
0.0|0.1|0.0|35|VIII(d) Other specified malignant bone tumors|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.0
~|~|~|~|VIII(e) Unspecified malignant bone tumors|80201013|0-19|All Races|Male and Female|2005|~|~|~
1.1|1.2|1.1|919|X Germ cell, trophoblastic tumors & neoplasms of gonads|80201013|0-19|All Races|Male and Female|2005|1.1|1.2|1.1
0.1|0.2|0.2|125|X(a) Intracranial & intraspinal germ cell tumors|80201013|0-19|All Races|Male and Female|2005|0.1|0.2|0.2
0.1|0.2|0.2|129|X(b) Malignant extracranial & extragonadal germ cell tumors|80201013|0-19|All Races|Male and Female|2005|0.1|0.2|0.2
0.7|0.8|0.7|608|X(c) Malignant gonadal germ cell tumors|80201013|0-19|All Races|Male and Female|2005|0.7|0.8|0.8
0.0|0.1|0.0|31|X(d) Gonadal carcinomas|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.0
0.0|0.0|0.0|26|X(e) Other and unspecified malignant gonadal tumors|80201013|0-19|All Races|Male and Female|2005|0.0|0.0|0.0
1.7|1.8|1.7|1420|XI Other malignant epithelial neoplasms and malignant melanomas|80201013|0-19|All Races|Male and Female|2005|1.7|1.9|1.8
~|~|~|~|XI(a) Adrenocortical carcinomas|80201013|0-19|All Races|Male and Female|2005|~|~|~
0.6|0.7|0.6|498|XI(b) Thyroid carcinomas|80201013|0-19|All Races|Male and Female|2005|0.6|0.7|0.6
0.0|0.1|0.0|33|XI(c) Nasopharyngeal carcinomas|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.0
0.6|0.7|0.6|528|XI(d) Malignant melanomas|80201013|0-19|All Races|Male and Female|2005|0.6|0.7|0.7
~|~|~|~|XI(e) Skin carcinomas|80201013|0-19|All Races|Male and Female|2005|~|~|~
0.4|0.5|0.4|343|XI(f) Other and unspecified carcinomas|80201013|0-19|All Races|Male and Female|2005|0.4|0.5|0.4
0.1|0.1|0.1|73|XII Other and unspecified malignant neoplasms|80201013|0-19|All Races|Male and Female|2005|0.1|0.1|0.1
0.0|0.1|0.0|30|XII(a) Other specified malignant tumors|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.0
0.0|0.1|0.1|43|XII(b) Other unspecified malignant tumors|80201013|0-19|All Races|Male and Female|2005|0.0|0.1|0.1
16.3|16.9|16.6|13186|All ICCC Groups Combined|78718627|0-19|All Races|Male and Female|2006|16.5|17.0|16.8
4.3|4.6|4.5|3533|I Leukemias, myeloproliferative & myelodysplastic diseases|78718627|0-19|All Races|Male and Female|2006|4.3|4.6|4.5
3.1|3.3|3.2|2519|I(a) Lymphoid leukemias|78718627|0-19|All Races|Male and Female|2006|3.1|3.3|3.2
0.7|0.9|0.8|630|I(b) Acute myeloid leukemias|78718627|0-19|All Races|Male and Female|2006|0.7|0.9|0.8
0.2|0.2|0.2|155|I(c) Chronic myeloproliferative diseases|78718627|0-19|All Races|Male and Female|2006|0.2|0.2|0.2
0.1|0.2|0.1|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78718627|0-19|All Races|Male and Female|2006|0.1|0.2|0.2
0.1|0.2|0.1|109|I(e) Unspecified and other specified leukemias|78718627|0-19|All Races|Male and Female|2006|0.1|0.2|0.1
2.3|2.6|2.5|1950|II Lymphomas and reticuloendothelial neoplasms|78718627|0-19|All Races|Male and Female|2006|2.4|2.6|2.5
1.2|1.3|1.2|991|II(a) Hodgkin lymphomas|78718627|0-19|All Races|Male and Female|2006|1.2|1.3|1.3
0.8|0.9|0.8|668|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78718627|0-19|All Races|Male and Female|2006|0.8|0.9|0.8
0.2|0.3|0.2|188|II(c) Burkitt lymphoma|78718627|0-19|All Races|Male and Female|2006|0.2|0.3|0.2
0.1|0.1|0.1|80|II(d) Miscellaneous lymphoreticular neoplasms|78718627|0-19|All Races|Male and Female|2006|0.1|0.1|0.1
0.0|0.0|0.0|23|II(e) Unspecified lymphomas|78718627|0-19|All Races|Male and Female|2006|0.0|0.0|0.0
2.8|3.0|2.9|2275|III CNS and misc intracranial and intraspinal neoplasms|78718627|0-19|All Races|Male and Female|2006|2.8|3.0|2.9
0.2|0.3|0.3|214|III(a) Ependymomas and choroid plexus tumor|78718627|0-19|All Races|Male and Female|2006|0.2|0.3|0.3
1.3|1.5|1.4|1107|III(b) Astrocytomas|78718627|0-19|All Races|Male and Female|2006|1.3|1.5|1.4
0.6|0.7|0.6|479|III(c) Intracranial and intraspinal embryonal tumors|78718627|0-19|All Races|Male and Female|2006|0.6|0.7|0.6
0.4|0.5|0.5|381|III(d) Other gliomas|78718627|0-19|All Races|Male and Female|2006|0.4|0.5|0.5
0.0|0.1|0.1|44|III(e) Other specified intracranial & intraspinal neoplasms|78718627|0-19|All Races|Male and Female|2006|0.0|0.1|0.1
0.0|0.1|0.1|50|III(f) Unspecified intracranial and intraspinal neoplasms|78718627|0-19|All Races|Male and Female|2006|0.0|0.1|0.1
0.7|0.8|0.7|604|IV Neuroblastoma and other peripheral nervous cell tumors|78718627|0-19|All Races|Male and Female|2006|0.7|0.8|0.8
0.7|0.8|0.7|592|IV(a) Neuroblastoma and ganglioneuroblastoma|78718627|0-19|All Races|Male and Female|2006|0.7|0.8|0.8
~|~|~|~|IV(b) Other peripheral nervous cell tumors|78718627|0-19|All Races|Male and Female|2006|~|~|~
1.1|1.2|1.1|899|IX Soft tissue and other extraosseous sarcomas|78718627|0-19|All Races|Male and Female|2006|1.1|1.2|1.1
0.4|0.5|0.4|351|IX(a) Rhabdomyosarcomas|78718627|0-19|All Races|Male and Female|2006|0.4|0.5|0.4
0.1|0.2|0.1|102|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78718627|0-19|All Races|Male and Female|2006|0.1|0.2|0.1
~|~|~|~|IX(c) Kaposi sarcoma|78718627|0-19|All Races|Male and Female|2006|~|~|~
0.4|0.5|0.4|347|IX(d) Other specified soft tissue sarcomas|78718627|0-19|All Races|Male and Female|2006|0.4|0.5|0.4
0.1|0.1|0.1|96|IX(e) Unspecified soft tissue sarcomas|78718627|0-19|All Races|Male and Female|2006|0.1|0.1|0.1
0.0|0.0|0.0|25|Not classified by ICCC|78718627|0-19|All Races|Male and Female|2006|0.0|0.0|0.0
0.2|0.3|0.3|233|V Retinoblastoma|78718627|0-19|All Races|Male and Female|2006|0.3|0.3|0.3
0.6|0.7|0.7|527|VI Renal tumors|78718627|0-19|All Races|Male and Female|2006|0.6|0.7|0.7
0.5|0.6|0.6|468|VI(a) Nephroblastoma and other nonepithelial renal tumors|78718627|0-19|All Races|Male and Female|2006|0.5|0.7|0.6
0.0|0.1|0.1|53|VI(b) Renal carcinomas|78718627|0-19|All Races|Male and Female|2006|0.1|0.1|0.1
~|~|~|~|VI(c) Unspecified malignant renal tumors|78718627|0-19|All Races|Male and Female|2006|~|~|~
0.2|0.3|0.2|184|VII Hepatic tumors|78718627|0-19|All Races|Male and Female|2006|0.2|0.3|0.2
0.1|0.2|0.2|127|VII(a) Hepatoblastoma|78718627|0-19|All Races|Male and Female|2006|0.1|0.2|0.2
0.0|0.1|0.1|51|VII(b) Hepatic carcinomas|78718627|0-19|All Races|Male and Female|2006|0.0|0.1|0.1
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78718627|0-19|All Races|Male and Female|2006|~|~|~
0.8|1.0|0.9|718|VIII Malignant bone tumors|78718627|0-19|All Races|Male and Female|2006|0.8|1.0|0.9
0.5|0.6|0.5|416|VIII(a) Osteosarcomas|78718627|0-19|All Races|Male and Female|2006|0.5|0.6|0.5
0.0|0.0|0.0|18|VIII(b) Chondrosarcomas|78718627|0-19|All Races|Male and Female|2006|0.0|0.0|0.0
0.3|0.3|0.3|230|VIII(c) Ewing tumor and related sarcomas of bone|78718627|0-19|All Races|Male and Female|2006|0.3|0.3|0.3
0.0|0.1|0.0|39|VIII(d) Other specified malignant bone tumors|78718627|0-19|All Races|Male and Female|2006|0.0|0.1|0.0
~|~|~|~|VIII(e) Unspecified malignant bone tumors|78718627|0-19|All Races|Male and Female|2006|~|~|~
0.9|1.1|1.0|793|X Germ cell, trophoblastic tumors & neoplasms of gonads|78718627|0-19|All Races|Male and Female|2006|0.9|1.1|1.0
0.1|0.2|0.1|110|X(a) Intracranial & intraspinal germ cell tumors|78718627|0-19|All Races|Male and Female|2006|0.1|0.2|0.1
0.1|0.2|0.1|112|X(b) Malignant extracranial & extragonadal germ cell tumors|78718627|0-19|All Races|Male and Female|2006|0.1|0.2|0.1
0.6|0.7|0.6|510|X(c) Malignant gonadal germ cell tumors|78718627|0-19|All Races|Male and Female|2006|0.6|0.7|0.6
0.0|0.1|0.0|39|X(d) Gonadal carcinomas|78718627|0-19|All Races|Male and Female|2006|0.0|0.1|0.0
0.0|0.0|0.0|22|X(e) Other and unspecified malignant gonadal tumors|78718627|0-19|All Races|Male and Female|2006|0.0|0.0|0.0
1.6|1.8|1.7|1372|XI Other malignant epithelial neoplasms and malignant melanomas|78718627|0-19|All Races|Male and Female|2006|1.7|1.8|1.7
0.0|0.0|0.0|16|XI(a) Adrenocortical carcinomas|78718627|0-19|All Races|Male and Female|2006|0.0|0.0|0.0
0.6|0.7|0.7|535|XI(b) Thyroid carcinomas|78718627|0-19|All Races|Male and Female|2006|0.6|0.7|0.7
0.0|0.1|0.1|52|XI(c) Nasopharyngeal carcinomas|78718627|0-19|All Races|Male and Female|2006|0.0|0.1|0.1
0.5|0.6|0.5|436|XI(d) Malignant melanomas|78718627|0-19|All Races|Male and Female|2006|0.5|0.6|0.6
~|~|~|~|XI(e) Skin carcinomas|78718627|0-19|All Races|Male and Female|2006|~|~|~
0.4|0.5|0.4|330|XI(f) Other and unspecified carcinomas|78718627|0-19|All Races|Male and Female|2006|0.4|0.5|0.4
0.1|0.1|0.1|73|XII Other and unspecified malignant neoplasms|78718627|0-19|All Races|Male and Female|2006|0.1|0.1|0.1
0.0|0.1|0.0|39|XII(a) Other specified malignant tumors|78718627|0-19|All Races|Male and Female|2006|0.0|0.1|0.0
0.0|0.1|0.0|34|XII(b) Other unspecified malignant tumors|78718627|0-19|All Races|Male and Female|2006|0.0|0.1|0.0
